If information was available at all, the remaining studies enrolled only individuals with a stable disease based on CD4 count and HIV viral load as well as the absence of severe immunodeficiency with high recurrence of opportunistic infections, wasting disease, and disseminated malignancy in implant therapy. The gene discussed is CD4; the disease is Opportunistic infection.